Iradimed (IRMD) Change in Accured Expenses (2013 - 2026)

Iradimed (IRMD) has 14 years of Change in Accured Expenses data on file, last reported at -$1.2 million in Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at -$1.2 million, up 23.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $203000.0 (up 120.84% YoY), and the FY2025 annual result was -$150000.0, down 50.0% from the prior year.
• Change in Accured Expenses eased to -$1.2 million in Q1 2026 per IRMD's latest filing, from -$449420.0 in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $943389.0 in Q2 2025 and troughed at -$1.5 million in Q1 2025.
• A 5-year average of -$96097.1 and a median of -$7994.0 in 2022 frame the typical range for Change in Accured Expenses.
• On a YoY basis, Change in Accured Expenses climbed as much as 3227.35% in 2023 and fell as far as 618.85% in 2023.
• A 5-year view of Change in Accured Expenses shows it stood at $66838.0 in 2022, then slumped by 618.85% to -$346787.0 in 2023, then tumbled by 75.65% to -$609123.0 in 2024, then climbed by 26.22% to -$449420.0 in 2025, then tumbled by 156.33% to -$1.2 million in 2026.
• Business Quant data shows IRMD's Change in Accured Expenses at -$1.2 million in Q1 2026, -$449420.0 in Q4 2025, and $861031.0 in Q3 2025.